N/A N=50 Endoscopic Ultrasound Guided Fine Needle Biopsy (EUS-FNB-SC) Using a Novel Fork Needle
Pancreatic Cancer
Primary: Total DNA Yield of Adenocarcinoma — 5930.10; 3365.22 ng/µL — p=0.01
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=40 Comparison of 19g FNA and 19g FNB Needles for EUS-LB
Abnormal Liver Function
Primary: Pre-processing Length of the Longest Piece (LLP) — 1.47; 2.09 centimeter
N/A N=56 22G FNA Needle vs. 22G ProCore Needle
Pancreatic Neoplasm
Primary: Compare the Median Number of Passes Required to Establish a Diagnosis — 1; 1 No. of passes for diagnosis
N/A N=140 Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle
Pancreatic Cancer · Lymphadenopathy · Gastrointestinal Stromal Tumor
Primary: Diagnostic Yield of EUS-FNB and EUS-FNA — 67.1; 90 percentage of patients
N/A N=137 EUS-guided Fine Needle Aspiration (FNA) With and Without the Use of a Stylet
Biopsy, Fine-Needle · Biopsy, Fine-Needle/Methods · Endosonography
Primary: Compare Adequacy of Diagnoses in Passes With and Without a Stylet — 80; 68; 21; 18 passes
N/A N=60 Comparison of a Novel 22-gauge Core Biopsy Needle
Solid Pancreatic Mass Lesions · Malignant Neoplasm of Pancreas
Primary: Comparison of Diagnostic Adequacy Scores With SST vs. CST for Cytologic Diagnosis Using a 22G Core Needle. — 5; 6; 24; 24 Participants
N/A N=608 Comparing a 25G EUS Fine Needle Aspiration (FNA) Device With a 20G EUS
Pancreatic Masses · Lymph Nodes
Primary: Diagnostic Accuracy — 237; 263 Participants
N/A N=134 SharkCore Versus Acquire FNB
EUS Guided Biopsy
Primary: Is the Acquire Needle Non-inferior Compared to SharkCore Needle in Histologic Yield of the Sample Obtained? — 3; 4; 10; 14 Lesions
N/A N=258 Navigation Endoscopy to Reach Indeterminate Lung Nodules Versus Trans-Thoracic Needle Aspiration
Lung Nodule
Primary: Diagnostic Accuracy — 94; 81 Participants — p=0.003
N/A N=20 19 Versus 22-Gauge Needle for EUS-LB
Diagnoses Diseases · Ultrasound Therapy; Complications · Liver Diseases
Primary: Number of Specimens for Which a Histologic Diagnosis Could be Made Based Upon the Amount of Tissue Obtained With the Needle — 17; 14 specimens
Phase 3 N=121 Comparison of Two Needle Aspiration Techniques for Endoscopic Ultrasound-guided Fine Needle Aspiration (EUS-FNA) in Solid Pancreatic Lesions
Pancreatic Solid Lesions · Pancreatic Mass
Primary: Diagnostic Yield of Capillary Technique — 75.4 percentage of specimen
N/A N=61 Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Using a 22 vs 25-Gauge Needle
Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma · Lung Cancer
Primary: Percentage of Lymph Nodes With Adequate Samples — 79; 78.5 Percentage of Lymph Nodes
N/A N=56 Core Biopsy Endo Sonography Study Evaluation of the Significance of the Pro-core® Needle
Pancreatic Neoplasm
Primary: Diagnostic Accuracy — 84 Diagnostic accuracy (%)
N/A N=72 Trial Comparing 19 and 25-gauge EUS-FNA Needles
Cancer of Pancreas · Pancreatic Neoplasm
Primary: Median Number of Passes to Establish Diagnosis — 1; 1 No. of passes
N/A N=21 Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.)
Non-alcoholic Fatty Liver Disease · Nonalcoholic Steatohepatitis
Primary: Median Total Specimen Length — 8; 14; 8; 11.5 mm
N/A N=78 Evaluation of a New EUS-guided Needle (ProCore) Comparing to EUS-TCB Needle (Quick-Core)
GIST
Primary: Diagnostic Accuracy. — 88; 62 Percentage of participants
N/A N=246 EUS GUIDED Transduodenal Biopsy Using the 19G Flex
Abdominal Neoplasms
Primary: Capability of Performing EUS-FNTA Through the Duodenum by Placing the Target Lesion in the Proper Position With Insertion of the Needle Into the Lesion — 228 Participants
N/A N=26 Accuracy of Spybite Forceps When Compared to Conventional Sampling Methods
Accuracy of Tissue Diagnosis · Bile Duct Stricture · Pancreatic Duct Stricture
Primary: Percentage of Participants With Accurate Diagnoses of Cancer — 38.5; 53.9; 84.6 percentage of accurate diagnoses
N/A N=20 EBUS-Miniforceps Biopsy Specimen Acquisition for PD-L1 Testing in Nonsmall Cell Lung Cancer
Non Small Cell Lung Cancer · NSCLC
Primary: Feasibility of Utilizing Endobronchial Ultrasound Guided Miniforceps as Assessed by the Number of Participants From Whom Adequate Amounts of Tissue to Perform PD-L1…
N/A N=10 CrYobiopsy With Radial UltraSound Guidance
Pulmonary Disease
Primary: Time to Achieve Hemostasis After Obtaining Cryobiopsy — 146.55; 132.25 seconds — p=0.7878
N/A N=250 Evaluation of PCLs Using Three EUS-FNA Needles
Pancreatic Cystic Lesions
Primary: Volume of Aspirated Cyst Fluid as a Function of Estimated Maximal Volume — 78; 74; 73 percentage of cyst volume aspirated — p=0.84
N/A N=24 Pilot Study of Navigational Bronchoscopy and Transthoracic Needle Biopsy
Peripheral Pulmonary Nodules
Primary: Feasibility — 24 participants
N/A N=60 Evaluation of 19-gauge vs 21-gauge EBUS TBNA in Assessing Thoracic Lymphadenopathy
Enlarged Lymph Nodes (Excluding Infective)
Primary: Diagnostic Yield — 69; 68; 57; 57 lymph nodes
N/A N=20 Positron Emission Mammography (PEM) Biopsy Accessory for the Diagnosis of Breast Cancer
Breast Cancer
Primary: Feasibility That Breast Biopsy Can be Performed Using PEM and Stereo Navigator Software After Diagnostic PEM on the Same Day. — 22; 21; 6; 26 Breast Lesions
N/A N=153 Benign Liver Optimal Core Study (Tissue Acquisition Comparison in Benign Liver Disease)
Liver Diseases
Primary: Pathological Yield Fragmentation — 14; 11; 13; 10 mm
N/A N=67 A Prospective, Multi-site Clinical Study to Collect User Feedback Using Affirm® Contrast Biopsy
Breast Cancer
Primary: Number of Participants With Technical Success — 60 Participants
N/A N=339 Ultrathin Bronchoscope and Radial Endobronchial Ultrasound (R-EBUS) With Fluoroscopy Versus Standard Fiberoptic Bronchoscopy (FB) (P00029233 )
Pulmonary Lesions · Pulmonary Nodules · Pulmonary Mass
Primary: Diagnostic Yield of Procedures; Number of Positive Diagnosis of Pulmonary Lesions — 51; 62; 58; 51 participants
N/A N=9 Fusion Targeted Biopsy of the Prostate
Prostate Cancer
Primary: Cancer Detection by Targeted and Standard Biopsy Approaches
N/A N=51 Safety of a Sheath Cryoprobe Bronchoscopic Transbronchial Biopsy Technique
Lung Diseases
Primary: Number of Participants With Serious Adverse Events — 0 Participants
N/A N=500 Brevera™ Breast Biopsy System Data Collection Study
Breast Cancer Female
Primary: Procedural Time — 38.44 Minutes